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Abstract
Amyloid aggregates of the protein α-synuclein (αS) called Lewy Bodies (LB) and Lewy Neur-
ites (LN) are the pathological hallmark of Parkinson’s disease (PD) and other synucleinopa-
thies. We have previously shown that high extracellular αS concentrations can be toxic to
cells and that neurons take up αS. Here we aimed to get more insight into the toxicity mech-
anism associated with high extracellular αS concentrations (50–100 μM). High extracellular
αS concentrations resulted in a reduction of the firing rate of the neuronal network by dis-
rupting synaptic transmission, while the neuronal ability to fire action potentials was still
intact. Furthermore, many cells developed αS deposits larger than 500 nm within five days,
but otherwise appeared healthy. Synaptic dysfunction clearly occurred before the establish-
ment of large intracellular deposits and neuronal death, suggesting that an excessive extra-
cellular αS concentration caused synaptic failure and which later possibly contributed to
neuronal death.
Introduction
The three most common synucleinopathies are Parkinson’s disease (PD), Lewy body dementia
(LBD), and multiple system atrophy (MSA) [1]. In all these diseases, the protein α-synuclein
(αS) aggregates into amyloid fibrils which are deposited in characteristic inclusions, i.e. Lewy
bodies and Lewy neurites [1, 2]. The presence of Lewy bodies does, however, not always corre-
late with neurodegeneration and disease symptoms [3]. The relation between αS aggregation,
the formation of αS amyloid inclusions, clearance of aggregates, and the development of dis-
ease remains ill understood.
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The protein αS is constantly secreted into the extracellular space by αS expressing cells in
the brain [4]. More importantly, extracellular αS monomers and aggregates can be taken up by
other cells [5–8]. This uptake possibly contributes to spreading of αS aggregation throughout
the nervous system [9, 10]. In healthy cells αS function is associated with synaptic activity [11,
12] possibly by regulating the synaptic vesicle pool [13–15] via reclustering of vesicles after
endocytosis [16–18]. In αS knockout mice, however, no clear impairment of basic brain func-
tions or neuronal survival could be observed [19]. Therefore Chandra et al hypothesized that
αS may have a function in preventing the accumulation of non-native, potentially toxic mole-
cules during the continuous operation of axon terminals [20], like suggested for another abun-
dant protein, cysteine string protein alpha (CSPα) [21, 22].
It is estimated, on the basis of radioactive immuno blots and quantitative mass spectrome-
try, that the intracellular αS concentration accounts for ~0.5% of total brain protein [14, 23,
24]. With a protein concentration of about 100–200 mg/ml [25], this corresponds to a physi-
ological αS concentration of 35–70 μM in the human brain and ~40μM in the rat brain [26].
For Ubiquitin, cytoskeletal actin, and another Parkinson associated protein, UCH-L1, simi-
lar concentrations can be found in the cortex [23, 24, 27]. Mutations in the SNCA gene
encoding for αS are directly associated with the development of synucleinopathies and
decrease the disease onset [27, 28]. On average, a 1.6 times higher αS concentration is found
in neurons of the substantia nigra of elderly people than in young adults as observed by opti-
cal densitometry of immune stained tissue slices [29]. A recent post mortem study using
western blot showed a fivefold increase in αS concentration in the substantia nigra of brains
of MSA patients and a twofold increase in the striatum of MSA and PD patients, as compared
to post mortem brains not diagnosed as MSA or PD [30]. Thus, under pathological condi-
tions, local intracellular αS concentrations well above 100 μM are possible, but large differ-
ences are found between different cell types and part of the increase can be attributed to
presence of αS in inclusion bodies [31]. Much lower concentrations have also been reported
in other cell types [32]. Although αS concentrations in cerebrospinal fluid are on average in
the nM range (1–300 pg/μl) [33], the extracellular concentration may locally rise much
higher, e.g. in case of cell rupture or sudden cell death as a result of mild brain trauma [34,
35]. The extracellular concentration in such cases is unknown, but it may locally increase
towards the intracellular concentration. This extracellular αS is possibly removed due to re-
uptake by glial cells and neurons [36, 37], transport from CSF to the blood serum [38, 39]
and degradation by extracellular matrix proteases [40–43]. Earlier work showed that neurons
take up excessive αS, leading to the formation of Lewy body like inclusions [37]. The physio-
logical goal of this process remains unclear. Recent work suggests that the formation of LBs
occurs simultaneously with synaptic impairment and neuron death, but the exact mecha-
nisms remain unknown [11, 12]. Neuronal uptake of excessive αS has been suggested to be a
cellular defense mechanism [44], or to occur as a consequence of the physicochemical condi-
tions in the cell [45], which may in evolutionary perspective be strongly associated. Either
way, biology may have found ways to prevent buildup of excessive extracellular αS. There-
fore, we hypothesize that temporal excessive extracellular αS might be an initiator of αS
related pathology.
We exposed cultured rat cortical networks on multi electrodes arrays (MEAs) to recom-
binantly expressed human αS (hαS), to investigate the possible detrimental effects of high
concentration extracellular αS, e.g. conditions where the extracellular αS concentration
approaches the intracellular concentration. Furthermore, we determined if and at what rate LB
like inclusions are formed, and investigated the sequence of events that eventually lead to neu-
ronal cell death.
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Materials and methods
Recombinant proteins and reagents
The expression of human wild type αS (hαS) and the A140C mutant (hαS 140C) with a single
alanine to cysteine substitution at residue 140 was performed in E. coli B121 (DE3) using a
pT7 based expression system. Details on the purification procedure of recombinantly pro-
duced hαS are described elsewhere [46]. Purified protein was stored at -80˚C in aliquots until
further use. The hαS A140C monomers were conjugated with AlexaFluor488 maleimide fol-
lowing the manufacturer’s labeling protocol (Life Technologies, USA). Antibodies specific for
αS, Amino acids 15–123, 123–140, and 96–140 were obtained from BD biosciences, Abcam,
and Santa Cruz Biotechnology, respectively. Rabbit anti-MAP2 antibodies and all Alexa dye
coupled secondary antibodies were acquired from Invitrogen.
Aggregation of recombinant hαS
Aggregation of hαS was monitored using the amyloid binding dye Thioflavin T (ThT; excita-
tion: 446nm, emission: 485nm). Fibrilization reactions were set up using 0, 10, 20, 50 and
100 μM αS and 20 μM ThT in R12 medium. The aggregations reactions were performed in
200 μl volume in 96 well plates with optically transparent bottoms, sealed with adhesive film in
6 fold, at 37˚C under quiescent conditions and monitored using a Safire microplate reader
(Tecan). The fluorescence intensity was recorded every 15 minutes for 8 days. Before each
reading the samples were subjected to five seconds orbital shaking to homogenize the samples.
To enable interpretation of intensity values, a control 100 μM sample in 10mM NaCl, 10mM
Tris buffer was prepared and allowed to aggregate at 37˚C with orbital shaking. Apart from the
orbital shaking the ThT fluorescence intensity of these samples was followed in time under the
same experimental conditions. Additionally, pre- and post- ThT incubation samples were
loaded on native 4–12 gradient PAGE gels. As a positive control, αS was oligomerized as
described elsewere [47].
Atomic force microscopy. Atomic force microscopy (AFM) samples were prepared by
adsorbing 10 μl of undiluted R12 medium or undiluted solutions of αS incubated in R12
medium for 8 days on freshly cleaved mica for 4 minutes. These samples were subsequently
gently washed twice with 100 μl Milli-Q water and dried using a gentle stream of nitrogen gas.
AFM images were acquired on a Bioscope Catalyst (Bruker) in tapping mode in air using a sili-
con probe (NSC36, tip B; Mikromasch). All images were captured with 512x512 pixels at a
scan rate of 0.5 or 2.0 Hz. The images were plane corrected using Scanning Probe Image Pro-
cessor (SPIP)-6.0.13 software (Image Metrology).
ANS binding assay. To detect and characterize partially folded oligomeric αS species [48]
a 200 μM 1-anilinonaphthalene- 8-sulfonic acid (1,8-ANS) stock solution in methanol was pre-
pared. From the aggregation reactions 50 μl aliquots were diluted to 2 ml in 10 mM Tris-HCl,
pH 7.4 and 40 μl of 1,8-ANS stock solution was added. As a reference sample 40 μl of 1,8-ANS
stock solution was added to 2 ml of 10 mM Tris-HCl, pH 7.4. Fluorescence emission spectra
were recorded on a Cary Eclipse fluorescence spectrophotometer (Varian) with excitation at
395 nm and emission detection from 410 to 600 nm using 5 nm slit widths.
Primary neuron extraction and culture
The extraction and culturing of primary neurons was performed as described elsewhere [49].
In short, cells were obtained from newborn Wistar rats from an in-house breeding program
using rats obtained from Harlan, Horst, the Netherlands. Rats were decapitated with no prior
anesthesia, cortices were isolated, and cells were dissociated by trypsinization and trituration
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and subsequently cells were plated on polyethyleneimine (PEI; Acros Organics, USA)-coated
culture dishes with glass bottoms or PEI-coated coverslips to ~60% density. After 2 hours,
adhered cells were washed with Dulbecco’s Modified Eagles Mediun (DMEM; Invitrogen,
USA) and cultured in 900 μl, serum-free R12 medium [50] at 37˚C with 5% CO2. Medium
was refreshed twice a week by replacing one third of the medium by the same amount of
fresh medium. After three weeks cultures were mostly confluent, and were considered
mature.
For electrophysiological experiments, cells were plated on multi electrode arrays (MEA;
Multi Channel Systems, Reutlingen, Germany), containing 60 titanium nitride electrodes
(30 μm diameter and 200 μm pitch). Cells were plated on MEAs at a final density of approxi-
mately 2500 cells/mm2. For experiments 50 or 100 μM αS was added to mature neural net-
works. As a control the small stable moderately non-reactive protein bovine serum albumin
(BSA; Sigma-Aldrich; 100 μM) was used. For electrophysiological recordings, we firmly sealed
the culture chambers with watertight but CO2 and O2 permeable foil (MCS; ALA scientific),
and placed the cultures in a measurement setup outside the incubator while maintaining tem-
perature, pCO2, and humidity. Experiments lasted five to seven days. During experiments the
culture medium was refreshed once, after four days. Fresh medium did not contain new αS or
BSA. All experiments were done at least 20 days after plating. Recordings began after an
accommodation period of 20 minutes. All procedures involving animals were conducted
according to Dutch and European laws and guidelines, and approved by the Dutch Animal
Use Committee (DEC).
Immunocytochemistry
Cell samples were washed with PBS and fixed in 3.7% paraformaldehyde/PBS solution. For
immunolabeling, cells were permeabilized with 0.3% Triton X-100 and 0.1% BSA in PBS.
Autofluorescence was quenched with 50 mM NH4Cl in PBS. Primary antibodies were applied
in 16% goat serum, 0.3% Triton X-100, 0.3 M NaCl in PBS, and incubated overnight. Subse-
quently, cells were washed three times with 0.3% Triton X-100 and 0.1% BSA in PBS at room
temperature. Secondary antibodies were applied in same buffer and incubated for one hour.
For ThioflavinS (ThS) or phalloidinalexa647 staining, fixed cells were incubated with 0.05%
ThS or 70 nM phalloidinalexa647 in PBS for 15 minutes. Nuclear counterstaining was per-
formed by incubation in 300 nM 4’,6-diamidino-2-phenylindole (DAPI) in PBS for 10 min-
utes. After washing with PBS, samples were mounted with mounting medium (Ibidi,
Germany).
Confocal microscopy
Confocal laser scanning microscopy images were obtained on a Zeiss LSM510 Confocal micro-
scope with a 63x oil immersion objective (NA = 1.4, Zeiss, Germany). Images were taken suc-
cessively, and were analyzed with the ZEN software 2009 (Zeiss, Germany).
Quantifying the number of αS deposits
To quantify the number of αS deposits, images of three random regions (150 x 150 μm) of
samples immunolabeled for αS were obtained at different time points with confocal micros-
copy. The fluorescence intensity from the αS deposits is typically very high. In the image analy-
sis procedure we therefore set a threshold above which only αS deposits were visible. The same
threshold was applied to all images. The αS deposits and cells (DAPI) per image were counted
and averaged.
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Immunoblot analysis
Cells were incubated in buffer [4x Laemmli buffer (8% SDS, 240 mM Tris-Cl, pH 6.8), 100
mM DTT] for 15 minutes at room temperature and transferred to Eppendorf tubes. The sam-
ples were boiled for five minutes and centrifuged for two minutes at 12000 rcf (IEC Micro-
MAX tabletop centrifuge). Subsequently, the proteins in the samples were separated on a 12%
SDS-PAGE gel. The resulting gel was imaged (excitation.: 488 nm, emission.: 510–600 nm) on
a gel imaging system (Gel DocTM, Bio-Rad, USA).
Metabolic activity assay/ live dead assay
Cells seeded in 24-well plates (Greiner Bio-One GmbH, Germany) were incubated with
100 μM hαS monomers or 100 μM rotenone for one, five, or seven days. Rotenone was used as
positive control for toxicity. Cells were incubated with 0.5 mg/ml 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT) in medium for four hours at 37˚C in an atmosphere
containing 5% CO2. The medium was discarded carefully and cells were solubilized in DMSO.
After cell solubilization, the metabolic activity was quantified in a multiwell plate reader by
measuring the absorbance at 540 nm (Tecan Ltd, Switzerland). The background absorbance
was determined at 690 nm and subtracted from the MTT signal. The MTT data of treated
groups were normalized to a control at the same time point. In short, cells were plated on glass
cover slips, washed with cold PBS and incubated with 100 μl/ml solution of propidium iodide
(PI) and/or annexin V (Invitrogen, USA) for 15 minutes at room temperature. Subsequently,
cells were washed with binding buffer. Images were obtained using an inverted fluorescence
microscope (EVOS, AMG, USA) with a 20x objective (N.A. = 0.4, EVOS, USA).
Activity recording and wave shape analysis
Action potentials (spikes) on MEAs were measured extracellularly, generally with a negative
potential [51]. We calculated the array wide firing rate (AWFR) as the summed activity of all
electrodes in one hour time bins. In continuous recordings, 12 consecutive bins were averaged
to monitor AWFR at a temporal resolution of two samples/day. In discontinuous recordings
(particularly control experiments with BSA), all one hour bins with an AWFR value that fell
within a 48h interval were averaged per culture, and then averaged across cultures. AWFR gen-
erally increases during the first three weeks after plating. After that, from week three to week
seven, predominantly minor fluctuations are observed and a fairly stable mean firing rate on a
time scale of hours to days can be observed [52]. Firing patterns usually contained periods of
seemingly uncorrelated firing, alternated by periods of highly synchronized firing at many
electrodes (network bursts). Data were recorded from all electrodes at a sample rate of 16 kHz,
using a custom Labview (National Instruments, Austin (Tx), USA) program. Potential spikes
were stored whenever the signal exceeded a predefined threshold of 5.5 times the estimated
noise level (which was continuously updated). For each spike, the program stored the time
stamp, the recording electrode and 6 ms of the spike waveform (from 2 ms before to 4 ms after
the threshold crossing).
Stored wave shapes were used for off-line artifact detection following the procedure
described in [53]. If αS affects neuronal viability, or, more generally, the resting membrane
potential [54], this is also reflected in a change in the action potential, which can be detected in
extracellular potential recordings [55]. In MEA recordings, electrodes may pick up signals
from more than one neuron. For this analysis, however, we selected electrodes that recorded
activity from a single neuron, following the approach introduced in [56]. In short, a measure is
calculated for the variability of action potential shapes at each electrode. Electrodes with suffi-
ciently low variability during baseline were considered as single neuron electrodes. Wave
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shapes were averaged per electrode in 1 h time bins. In each bin we calculated the relative
amplitude (normalized to baseline) and the correlation coefficient between the action potential
shape of that hour and those of all preceding hours. All activity of individual cultures was nor-
malized to the baseline activity before averaging across cultures. Finally, for each neuron, the
time of last activity was determined. Neurons with a correlation coefficient of more than 0.9
and a relative amplitude of more than 0.75 at the time of last activity, were considered to have
unchanged action potential shapes.
In addition to spontaneous activity recordings, some cultures were electrically stimulated
during 25 minutes per two hours. In these experiments, all data recorded from the start of the
stimulation period until 10 minutes after this period were excluded for the analysis of sponta-
neous activity, wave shape, and synchronicity (see below).
Burst synchronization analysis
Synchronized network bursts depend on synaptic transmission, and as such provide a suitable
indicator of synaptic functioning. To analyze the relative occurrence of network bursts we
determined a burstiness index (BI) [57]. In short, five minute recordings were divided into 300
(1s) time bins and the total number of spikes in each bin, summed across all electrodes, was
counted. The number of spikes in the 45 bins (15% of all bins within the 300 s period) contain-
ing the largest spike counts (f15) was expressed as a fraction of the total amount of spikes in
that 300 s period. Should most of the spikes occur in bursts, f15 will be close to 1; tonic firing
should lead to f15 0.15. We then defined a BI such that BI = (f15-0.15)/0.85, such that BI is
normalized between 0 (no bursts) and 1 (burst dominated). Five minute periods with less than
600 spikes were excluded from this analysis.
Stimulation experiments
Diminishing neural activity after αS addition may reflect decreased neuronal excitability or
impeded synaptic transmission. To differentiate between these two possible causes of reduced
activity, cultures were electrically stimulated (bi-phasic square pulses, 200 μs per phase, 16–
32 μA, one stimulus pulse per 10 seconds during 25 minutes per two hours). [58]. Electrical
stimulation has been shown to induce a response in two phases. The first phase results pre-
dominantly from direct stimulation of neurons in the near proximity of the stimulating elec-
trode and (antidromic) activation of axons in this area [59, 60]. The second phase, called
network or synaptically mediated response, results from synaptically propagated signals neu-
rons that fired in the first phase to connected neurons, thus creating a wave of activity through-
out the network. The first phase (early response) is relatively fast, it typically terminates within
5–15 ms, and besides directly induced action potentials it may contain some synaptically
induced spikes [61]. The synaptically mediated response, typically 15–300 ms after the stimu-
lus, can be completely abolished by Glutamatergic receptor antagonists (2R)-amino-5-phos-
phonovaleric acid (APV) and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) [62]. All
cultures were stimulated using three pre-selected electrodes that were able to trigger a good
network response. The lowest amplitude that was able to induce a network response was deter-
mined, usually in the range of 16–32 μA. The stimulation protocol consisted of pseudo random
stimulation of the three selected electrodes at 10 seconds intervals. Each electrode was stimu-
lated 50 times, resulting in a total stimulation period of 25 minutes. The stimulation period
was repeated every two hours. Only stimulation electrodes that showed an averaged, (com-
bined direct and late) response of at least 60 action potentials per stimulation during baseline
measurements were included in this analysis.
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Results
Recombinant hαS does not aggregate into amyloid fibrils in medium
After eight days of incubation of hαS in medium the ThT fluorescence intensity of this solu-
tion was comparable to the ThT intensity observed for the buffer control sample. Moreover,
the ThT intensity did not increase with increasing hαS concentration (Fig 1A). The ThT inten-
sity of medium containing hαS was two orders of magnitude lower than that of control sam-
ples containing αS amyloid fibrils, suggesting that no amyloid fibrils were formed. The
absence of amyloid fibrils in medium was confirmed in AFM images. However, the images
show small structures with a height of approximately 10 nm (Fig 1C). Although this height
agrees with the diameter observed for αS oligomers [47, 63], similar structures are found for
R12 medium deposited on mica (Fig 1D). We did not observe any difference in ANS fluores-
cence between R12 medium with or without 100 μM αS (Fig 1B). Western blots of hαS in R12
medium, made after five days of incubation, showed very low amounts of oligomeric αS (Fig
1E). Control blots indicated that these oligomeric species were already present before R12
incubation. We therefore conclude that in the experimental time frame no fibrils are formed
but the solution does contain small amounts of oligomeric αS species.
Primary neurons contain endogenous αS and take up extracellular αS
We tested eight neuronal cultures for expression of rat αS (rαS) by immunoblot analysis at dif-
ferent time points. Two weeks after plating we observed expression of rαS. The molecular
weight of the endogenous rαS is comparable to that of recombinant expressed human αS
(hαS). After three weeks we observed increased expression of both endogenous rαS and the
neuron specific marker MAP2, while the expression of the housekeeping enzyme GAPDH
Fig 1. hαS does not aggregate into amyloid fibrils in R12 medium. A) Fluorescence intensity of the amyloid binding dye ThT as a function of
the hαS concentration after incubation in R12 medium for eight days at 37˚C (blue) and hαS fibril control sample (red). B) Fluorescence
spectra of 1,8-ANS incubated in R12 medium for eight days at 37˚C in the presence of 100 μM hαS (red) and without hαS (blue). As a reference
the fluorescence spectrum of 1,8-ANS in 10 mM Tris-HCl, pH 7.4 is shown (purple). C) Representative atomic force microscopy (AFM) height
image of a 50 μM hαS sample after eight days of incubation in R12 medium indicating that the samples contained small structures. D) In AFM
images of the deposited R12 medium with no added hαS similar structures were found as those observed in C). E) Native western blot showing
hαS after incubation in 10mM Tris buffer or R12 medium for 0 and 5 days at 37˚C.
https://doi.org/10.1371/journal.pone.0193763.g001
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stayed constant (Fig 2A), indicating that neurons matured during that time. Quantification of
the rαS expression using the blot and taking recombinant hαS as a standard (Fig 2A lanes
8–10) resulted in an estimate for the total concentration of rαS of 20–50 μM αS at 21 days in
vitro (DIV). This is comparable to the rαS concentration in rats reported by others [26].
Immunostaining of the cells showed that rαS was expressed only in MAP2 positive neurons/
cells (Fig 2B) and homogeneously distributed throughout the cell.
To visualize the uptake of extracellular hαS, fluorescently labeled monomeric hαS (hαS
alexa488) was added to the culture medium. With confocal microscopy, we observed signifi-
cant uptake of hαS alexaA488 by cells within six hours after addition, in both cytoplasm and
nucleus (Fig 2C).
Exogenously added hαS hardly affects cell viability and metabolic activity
Increased amounts of endogenous αS can be toxic to cells [11, 64–72]. To investigate whether
this also applies to exogenously added hαS, we evaluated the cytotoxic effect of externally
Fig 2. Primary neuronal cells express endogenous rαS and neuronal marker MAP2. A) Immunoblot of cell lysate of primary neuronal
cells after 14 days shows immuno-reactivity for MAP2 and αS. B) Cells were fixed and fluorescently labeled; red: phalloidin alexa647,
cyan: αS alexa594, green: anti-MAP2 alexa488, blue: DAPI; confocal microscopy; scale bar 10 μm. C) Cells were treated with 100 μM labeled
hαS alexa488 and unlabeled hαS monomers (ratio 1:3) for six hours and processed as in B; red: phalloidin alexa647, green: exogenous
hαS alexa488, cyan: anti-αS alexa594 (endogenous rαS and exogenous hαS), blue: DAPI; confocal microscopy; scale bar 5 μm.
https://doi.org/10.1371/journal.pone.0193763.g002
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applied hαS on the cultures of primary rat neurons. Exposure to hαS did not affect cell sub-
strate adhesion as we did not observe increased cell detachment, compared to the control
group (data not shown). Neither the live-dead marker, propidium iodide, nor the apoptotic
marker Annexin V, showed a significant increase in positive cells for hαS exposed samples
compared to control cells (hαS 1.3 ± 1.4% compared to control 1.8 ± 2.0%, P = 0.34 (t-test)
and hαS 7.2 ± 7.2% compared to control 3.8 ± 3.4%, P = 0.51, respectively) after seven days of
treatment.
Since we did not detect an effect on cell viability, we next evaluated whether exogenously
added hαS has an effect on the metabolic activity as measured in a MTT assay. Metabolic rates
tended to increase immediately after exposure to hαS to 131.6 ± 8.4%, compared to control
samples (P = 0.25; t-test). After seven days metabolic rates had returned to control values
(102.1 ±7.7%). In the presence of rotenone, a significant decrease of metabolic activity was
observed after addition (47.2 ±2.0%; data not shown in Figure).
Exogenous hαS promotes intracellular αS deposit formation
To assess if the high extracellular hαS concentration induced the formation of αS deposits,
cells treated with hαS were immunolabeled for αS and analyzed by confocal microscopy. Fig
3A shows that αS deposits larger than 500 nm were formed within seven days. Occasionally
deposits were also actin positive, indicating their intracellular location, as visible in Fig 3A,
middle white arrow. A more detailed characterization of αS deposits can be found in Raiss
et al. 2016 (Sci Rep). The number of αS deposits increased in time (Fig 3B–3H). Whereas only
Fig 3. Exogenous hαS induces αS deposit formation in primary cortical cells. Cultured cortical cells were exposed to 100 μM hαS monomers
for one, five and seven days. Cells were fluorescently labeled with actinphalloidin647: red and anti-αS alexa594: green; confocal microscopy; A) After
hαS exposure, αS deposits were observed in the cells. Note the actin positive staining of deposit (middle arrow), confirming the intracellular
location. B-C) αS deposits formed in control cells. D-F) αS deposits formed in cells exposed to exogenous hαS. G-H) Magnification of αS
immunolabeled cell cultures at day seven. I) The number of αS deposits per cell; n = 3 for all groups; paired student’s t-test:  indicates P<0.05;
scale bar 5 μm (A), 50 μm (B-F) and 10 μm (G-H); αS deposits are indicated by white arrows.
https://doi.org/10.1371/journal.pone.0193763.g003
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few αS deposits were found after one day of αS exposure, about a third of the cells contained
an αS deposit by day five, and 75% of all cells contained a deposit by day seven (Fig 3I).
Exogenous hαS alters neuronal activity and burst synchronization but
leaves the action potential amplitude and shape unchanged
In eight cultures, we recorded electrophysiological activity, and we investigated the effect of
the added recombinant hαS. Initially, all cultures were active (9.9 ± 2.3 (SEM) spikes per sec-
ond) and their activity patterns included periods of highly synchronized action potential firing,
i.e. all cultures regularly showed network bursts. The array wide firing rate showed an initial
increase, directly after administration of hαS, which lasted from a few hours up to a full day.
The magnitude of the increase varied per experiment as reflected by the relatively large error
bars (Fig 4D). After the initial increase, the AWFR decreased and dropped below baseline val-
ues within approximately 24 hours. The firing rate decreased significantly until day five, when
hardly any activity could be recorded (one-way ANOVA: p<0.01, Fig 4D and compare Fig 4A
and 4B). Whereas initially action potentials were recorded at most electrodes, with time an
increasing number of electrodes became silent particularly beyond day three (p<0.001, Fig
4C). The burstiness index remained stable for the first two days and then decreased signifi-
cantly (p<0.001, (Fig 4E). After five days the activity was too low to calculate the burstiness
index. In four control cultures treated with 100 μM BSA, only the number of active electrodes
decreased with time (one-way ANOVA: p<0.02), but to a significantly lesser extent than in
hαS treated cultures (two-way ANOVA: p<0.05). AWFR and burstiness were not significantly
affected (p = 0.18 and p = 0.29, respectively, Fig 4C and 4E).
We next analyzed the temporal development of the shapes of the action potentials, at those
electrodes that recorded single unit activity. Each presented action potential is the average of
all action potentials recorded at a particular electrode within a one-hour period. Superposition
of all resulting averaged action potentials of a representative electrode clearly shows that shape
and amplitude of the averaged action potential remained constant throughout the experiment
(Fig 4F). This constant shape of the action potential over time was observed at the majority of
the selected electrodes. Fig 4H shows that a significant portion (60%) of neurons had
unchanged action potential shapes when they stopped firing. (Fig 4G and 4H). In contrast to
the 100% silencing observed in αS treated cultures, only 50% of the neurons had stopped firing
after eight days in cultures treated with BSA. Of those neurons only 5% showed unchanged
action potentials. Remarkably, most action potential shapes, if changed at all, did not change
gradually over time, but rather suddenly during the last hours before they stopped firing, as
shown in Fig 4G right panel.
Synaptic transmission is hampered in hαS exposed neurons
To assess the quality of synaptic transmission, early (5–15 ms latencies) and late responses
(15–300 ms) to electrical stimulation were measured and normalized to baseline responses
(before the addition of hαS, Fig 5A). Late responses started to decrease almost directly after
hαS administration whereas early responses remained around baseline for two days. The late
response continuously decreased for four days until we were no longer able to measure any
late responses (Fig 5B). A similar temporal evolution was observed when αS was administered
at 50μM for both late response (two-way ANOVA: p = 0.17 Fig 5B) and AWFR (two-way
ANOVA: p = 0.28 Figs 5C and 4D). Two control cultures treated with BSA were electrically
stimulated, late responses remained above 80% of their baseline response for at least 40 and
100 hrs, respectively, after which the recordings were stopped (data not shown).
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Fig 4. Exogenous hαS decreases neuronal activity and synchronicity of neuronal action potential firing pattern. Rat primary cortical cells were cultured for
three weeks and subsequently exposed to either 100 μM hαS or BSA. Neuronal activity was recorded using microelectrode arrays. A) An example of baseline
neuronal activity. On the vertical axis, all 60 electrodes are indicated and each tick in the corresponding row represents an action potential. During baseline
recordings, started 30 minutes before hαS administration, on average around 50 of the 60 electrodes were active and all activity patterns included network bursts
(synchronous firing at all or most electrodes, visualized as ‘vertical columns’). B) Recording of the same network four days post hαS administration. C-D) The
average number of active electrodes and Array wide firing rate (AWFR; the summed activity of all electrodes in one hour time bins, divided by the bin length)
were registered for eight days from eight αS treated cultures (blue) and three BSA (red) [95] treated cultures. E) Neuronal synchronicity slightly increased for
two days and then decreased, as indicated by the development of the burstiness index. BSA treated cultures initially showed a similar pattern but here the
burstiness recovered after four days F) The action potential shapes and the activity (dots; inset) of a representative neuron at different timepoints (color shift; day
0 = blue, day 7 = red) after addition of αS. G) Examples of neurons with unchanged and changed wave shapes. Top row, overlay of action potentials from every
hour color coded as in F. Middle row, correlation coefficients at every hour. Bottom row, action potential amplitudes at every hour. Note the drop in correlation
coefficient and amplitude in the last hours in right versus left panel. H) Cumulative histogram showing the fraction of all neurons, with reproducible baseline
action potential shape (n = 115), that became inactive in time. Blue indicates all neurons, red shows the fraction of neurons for which the action potential shape
changed before becoming inactive. C-E: Error bars represent SEM; n = 8 independent experiments.
https://doi.org/10.1371/journal.pone.0193763.g004
Fig 5. hαS interferes with intercellular communication. Networks of primary cortical rat neurons are electrically
stimulated before (day 0) and after administration of 100 μM hαS. A) The first 15 milliseconds after stimulation are
dominated by action potentials that were directly triggered by the stimulus pulse (early response; E). These early action
potentials are then synaptically propagated through the network and neurons at other electrodes respond up to 300
milliseconds after the stimulation (late response; L). Time progress is visualized by shifting color from blue (day 0) to
red (day 5), every line represents the averaged result of 12 stimulation periods (600 stimulations). B) Average
development of early and late response after addition of 50 or 100 μM αS, normalized to baseline values. C) Average
activity for neural networks treated with 50 μM αS. n = 9 electrodes in three different preparations for each condition.
https://doi.org/10.1371/journal.pone.0193763.g005
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Discussion
Cascade of events
Within six hours after the administration of monomeric hαS to mature neural networks
derived from rat cortical cells, we observed uptake of fluorescently labeled hαS. Although pos-
sible mechanisms on how extracellular proteins can enter the cytoplasm have been proposed,
the exact mechanism remains unclear [73]. Between 24 to 48 hours after hαS addition, net-
work excitability started to decrease, as demonstrated by the vanishing synaptically mediated
phase of the responses to electrical stimulation. Network excitability may be defined as the
average network response to a small stimulus, and thus covers neuronal excitability and synap-
tic efficacy. Network synchronicity (burstiness) also dropped, confirming the decreasing net-
work excitability. Two days after hαS administration, network excitability dropped to almost
zero, but individual neurons were still intact and functioning as demonstrated by the remain-
ing high number of active electrodes, of which action potential shapes and amplitudes were
unaffected. At that time, the increase in intracellular hαS concentration resulting from uptake
of monomeric protein had resulted in the formation of αS deposits in only a few cells. It gener-
ally took five days before one third of the cells contained at least one deposit. Electrophysiolog-
ical changes, reflected by a decrease in the number of active electrodes, were observed much
earlier, between three and four days after αS administration. This decrease in the number of
active electrodes might suggest that cells became fully dysfunctional and died. However, cell
death and metabolic assays did not support this, leaving the conclusion that the number of
active electrodes probably decreased because of decreased network excitability (Fig 4D). Thus,
network excitability significantly dropped long before LB like deposits became visible. The
time line of the events observed in this study are summarized in Fig 6. It seems unlikely that
the effect on network excitability and the consequent drop in network activity result from the
presence of large intracellular αS deposits. The relatively late formation of inclusion bodies is
in agreement with a study by Volpicelli et al [11], who saw first inclusion bodies four days post
addition of preformed fibrils.
Fig 6. Timeline of events. Three weeks after plating, when neural networks were considered mature, cortical cell cultures were
treated with 100 μM αS. Within the first day after αS addition spontaneous synaptic activity rose while electrically induced
network response started to decrease. Within two days after addition, spontaneous activity and the number of electrodes on
which activity was recorded dropped below baseline. At day five, on average, about one third of the cells had an inclusion body.
By day six hardly any spontaneous activity could be recorded and electrical stimulation was no longer able to evoke a network
response.
https://doi.org/10.1371/journal.pone.0193763.g006
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Interference with network functioning
The decrease in activity might result from neuronal dysfunction, increased inhibition, or from
massive synaptic failure. Although a decrease in network activity and failure of isolated synapses
in neuronal cultures treated with αS have been reported before [11, 12] we, for the first time,
show directly and in a large number of neurons, that impairment of network excitability after
addition of αS occurs before neuronal degradation. The fact that we were able to stimulate cells
directly while spontaneous activity was reduced significantly and action potential shapes and
amplitudes remained unaltered, supports the view that reduced activity is not due to neuronal
dysfunction. Interference of αS with specific non-synaptic ion channels in the neuronal mem-
brane [74] would alter wave shapes, as would other mechanisms that involve changes in mem-
brane conductance [75–79] or cell death [80]. Alternatively, decreasing activity might be caused
by activation of inhibitory receptors. If αS acts as a GABA agonist, we would expect an immedi-
ate drop in neural activity upon αS administration. During the first 24 hours, however, the total
firing rate increased, while the network response to electrical stimulation already decreased.
Therefore, it is unlikely that the eventual decrease in activity was due to increased inhibition.
Thus, we conclude that the activity decrease is most likely caused by massive synaptic failure.
Interference with synaptic functioning
Failure of synaptic transmission can take place at many different locations within the signaling
cascade. It has been reported that extracellular αS can block post-synaptic receptors directly
[81, 82]. At the cytosolic side of the post-synaptic membrane intracellular αS has been reported
to enhance internalization of NMDA receptors within 60 minutes [83]. One might speculate
that extracellular αS possibly sequesters neurotransmitter within the synaptic cleft, but experi-
mental evidence to support this view is lacking. Monomeric αS or small αS oligomers in the
medium might be responsible for such a mechanism, but it is highly unlikely that the intracel-
lular αS deposits are involved.
Alternatively, the excess αS or oligomeric αS aggregates may interfere at the presynaptic
side, e.g. in synaptic vesicle trafficking [16, 17] or the synaptic vesicle cycle [18]. Although olig-
omers may play a role in these mechanisms [63], it is improbable that large αS deposits are
responsible; synaptic failure occurs well before large scale cell death. Our analysis confirms
that synaptic dysfunction is responsible for synaptic failure, but our data does not allow further
differentiation between the above mentioned pre- or post-synaptic mechanisms. Characteriza-
tion of network activity in the presence of BSA showed that synaptic failure is not a generic
effect of surplus protein.
Initial activity increase
The underlying mechanism of the unexpected but robust initial activity increase remains unclear.
αS oligomers have been shown to increase the frequency of synaptic transmission due to their
pore forming properties [84]. Pro-inflammatory cytokines have been reported also to lead to
increased neuronal activity and may decrease firing synchronicity [85–88]. Although we have not
characterized our cultures for the presence of microglia [89, 90], this may have caused the observed
activity increase. Interesting in this respect is that we do see increased, usually uncorrelated activity
as well in early stages of bacterial infection of cultures (personal observation GH & JlF).
Concentration, aggregation and timespan of changes
Recent studies attributed different effects to specific different αS fibril species [12, 91]. In other
studies the time required to adjust firing patterns of neurons in response to the addition of
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‘fibril species was longer [11, 12] than the timespan of activity changes seen in response to the
addition of extracellular protein observed here. This slower response may reflect the lower αS
concentration used in those studies, up to 1 μM in extracellular assemblies. To mimic the max-
imal possible effect, we used 50–100 μM, a concentration equivalent to intracellular αS con-
centrations observed in rat neurons (Fig 2A) and reported in PD and LBD brains [14, 29, 30].
We show that an increased extracellular αS concentration may induce pathology. Though it
does not immediately result in cell death, neurons become isolated and network activity drops
dramatically. The rapid effect of exogenous αS on the synaptically mediated phase of stimulus
responses (within one day), suggests that it can be assigned to the presence of monomers or
small oligomers.
Toxicity
The addition of 100 μM hαS monomers had no noteworthy effect on cell viability or metabolic
activity on the time scales studied. In agreement with [92] the cytotoxic effects of αS exposure
are only small in primary cultures during the first weeks after exposure. The absence of a
severe cytotoxic effect (as in SH-SY5Y [37]) might be due to the presence of glial cells, which
generally fulfill a supporting function in neuronal networks. Suppressed synaptic functioning,
however, generally leads to decreased neuronal activity. Reliable synaptic transmission is
essential for regular calcium entry in postsynaptic neurons, which is needed for neuronal sur-
vival [93, 94] and the remaining activity may be insufficient for long-term neuronal survival. It
remains to be seen whether this discrepancy between cell death and loss of synaptic transmis-
sion can also be observed in neurons derived from other parts of the nervous system and
whether the same mechanism is present and crucial in the etiology of synucleopathies in
patients.
Conclusion
Combined, these data support the idea that synaptic failure is the primary effect induced by
high concentration of αS. Decreasing activity results from synaptic failure rather than neuro-
nal dysfunction. Neuronal death in our study may have occurred secondary to synaptic failure
due to insufficient remaining activity. This mechanism suggests that local high concentrations
of monomeric αS or perhaps small oligomeric αS species might play an important role in
synucleopathies.
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